首页>
外国专利>
Mutant anti-CTLA-4 antibody with improved immunotherapeutic effect but weakened side effects
Mutant anti-CTLA-4 antibody with improved immunotherapeutic effect but weakened side effects
展开▼
机译:抗CTLA-4突变型抗体,具有改善的免疫治疗效果,但副作用较弱
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to anti-CTLA-4 antibody compositions that bind to human CTLA-4 molecules, and to the use of the compositions in cancer immunotherapy and compositions that reduce autoimmune side effects compared to other immunotherapeutic agents.
展开▼